Sanofi EBIT 2010-2024 | SNY

Sanofi EBIT for the quarter ending September 30, 2024 was $4.204B, a 20.02% increase year-over-year.

  • Sanofi 2023 EBIT was 9.594B, a 10.51% decline from 2022.
  • Sanofi 2022 EBIT was 10.72B, a 8.88% increase from 2021.
  • Sanofi 2021 EBIT was 9.846B, a 39.92% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

Sanofi EBIT 2010-2024 | SNY

  • Sanofi 2023 EBIT was 9.594B, a 10.51% decline from 2022.
  • Sanofi 2022 EBIT was 10.72B, a 8.88% increase from 2021.
  • Sanofi 2021 EBIT was 9.846B, a 39.92% decline from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Innoviva (INVA)$1.2B